Directors' Dealings
March 23 2009 - 3:01AM
UK Regulatory
TIDMIMM
RNS Number : 2575P
Immupharma PLC
23 March 2009
+------------------------------------+------------------------------------+
| For Immediate Release | 23 March 2009 |
+------------------------------------+------------------------------------+
ImmuPharma PLC
Directors' Dealings
Institutions increase stake
ImmuPharma PLC ("ImmuPharma" or the "Company") (LSE:IMM) announces today that a
number of existing and new blue-chip institutional investors have purchased
shares from the Trusts of two of ImmuPharma's founders and Directors, Richard
Warr and Dimitri Dimitriou. The Trusts each placed 2.1 million (2.7 %) ordinary
shares of 10 pence each in the Company at a price of 82 pence per share to
institutional investors on 19 March.
Following the disposal, the current holdings are:
+------------------------+------------------------------------+------------+
| Richard Warr (1) | 9,778,968 ordinary shares | (12.6 %) |
+------------------------+------------------------------------+------------+
| | | |
+------------------------+------------------------------------+------------+
| Dimitri Dimitriou (2) | 9,778,969 ordinary shares | (12.6 %) |
+------------------------+------------------------------------+------------+
(1) Ordinary shares of GBP0.10 held by Louvre Trustees Limited where the Warr
family has a beneficial interest.
(2) Ordinary shares of GBP0.10 held by Louvre Trustees Limited where the
Dimitriou family has a beneficial interest.
Richard Warr, ImmuPharma's Chairman said:
"We are delighted with the demand from new investors, including several
blue-chip funds such as Gartmore, Smith & Williamson, Aviva and Rathbones. The
allocation of these shares increases ImmuPharma's free float with the aim of
improving overall liquidity."
For further information please contact:
+----------------------------------------------------+-------------------+
| ImmuPharma PLC: | +44 20 7152 4080 |
+----------------------------------------------------+-------------------+
| Dimitri Dimitriou, Chief Executive Officer | |
+----------------------------------------------------+-------------------+
| Richard Warr, Chairman | |
+----------------------------------------------------+-------------------+
| | |
+----------------------------------------------------+-------------------+
| Panmure Gordon | +44 151 243 0963 |
+----------------------------------------------------+-------------------+
| Andrew Burnett/ Rakesh Sharma (Corporate Finance) | |
+----------------------------------------------------+-------------------+
| Ashton Clanfield (Corporate Broking) | |
+----------------------------------------------------+-------------------+
| | |
+----------------------------------------------------+-------------------+
| Buchanan Communications: | +44 20 7466 5000 |
+----------------------------------------------------+-------------------+
| Lisa Baderoon | |
+----------------------------------------------------+-------------------+
| Rebecca Skye Dietrich | |
+----------------------------------------------------+-------------------+
More information on the company can be found at www.immupharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSSEWFWSSUSELD
Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024
